{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T13:15:09Z","timestamp":1791724509653,"version":"4.3.4"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1038\/ncpendmet0449","type":"journal-article","created":{"date-parts":[[2007,2,22]],"date-time":"2007-02-22T10:51:40Z","timestamp":1172141500000},"page":"260-269","source":"Crossref","is-referenced-by-count":113,"title":["Defects in iodide metabolism in thyroid cancer and implications for the follow-up and treatment of patients"],"prefix":"10.1038","volume":"3","author":[{"given":"Martin","family":"Schlumberger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovic","family":"Lacroix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiano","family":"Filetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Bidart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFncpendmet0449_CR1","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1056\/NEJM199801293380506","volume":"338","author":"M Schlumberger","year":"1998","unstructured":"Schlumberger M (1998) Papillary and follicular thyroid carcinoma. N Engl J Med 338: 297\u201330656","journal-title":"N Engl J Med"},{"key":"BFncpendmet0449_CR2","first-page":"331","volume-title":"Williams' Textbook of Endocrinology","author":"PR Larsen","year":"2003","unstructured":"Larsen PR et al. (2003) Thyroid physiology and diagnostic evaluation of patients with thyroid disorders. In Williams' Textbook of Endocrinology, edn 10, 331\u2013373 (Eds Larsen PR et al.) Philadelphia: WB Saunders"},{"key":"BFncpendmet0449_CR3","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1210\/er.2001-0029","volume":"24","author":"O Dohan","year":"2003","unstructured":"Dohan O et al. (2003) The sodium\/iodide symporter (NIS): characterization, regulation, and medical significance. Endocr Rev 24: 48\u201377","journal-title":"Endocr Rev"},{"key":"BFncpendmet0449_CR4","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/ng1297-411","volume":"17","author":"LA Everett","year":"1997","unstructured":"Everett LA et al. (1997) Pendred syndrome is caused by mutations in a putative sulphate transporter gene (PDS). Nat Genet 17: 411\u2013422","journal-title":"Nat Genet"},{"key":"BFncpendmet0449_CR5","doi-asserted-by":"publisher","first-page":"3500","DOI":"10.1210\/jcem.87.7.8797","volume":"87","author":"AM Rodriguez","year":"2002","unstructured":"Rodriguez AM et al. (2002) Identification and characterization of a putative human iodide transporter located at the apical membrane of thyrocytes. J Clin Endocrinol Metab 87: 3500\u20133503","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0449_CR6","first-page":"37625","volume":"274","author":"C Dupuy","year":"1999","unstructured":"Dupuy C et al. (1999) Purification of a novel flavoprotein involved in the thyroid NADPH oxidase. Cloning of the porcine and human cDNAs. J Biol Chem 274: 37625\u201337629","journal-title":"J Biol Chem"},{"key":"BFncpendmet0449_CR7","doi-asserted-by":"publisher","first-page":"23227","DOI":"10.1074\/jbc.M000916200","volume":"275","author":"X De Deken","year":"2000","unstructured":"De Deken X et al. (2000) Cloning of two human thyroid cDNAs encoding new members of the NADPH oxidase family. J Biol Chem 275: 23227\u201323233","journal-title":"J Biol Chem"},{"key":"BFncpendmet0449_CR8","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1210\/en.2005-0805","volume":"147","author":"F Bernier-Valentin","year":"2006","unstructured":"Bernier-Valentin F et al. (2006) Three-dimensional organization of thyroid cells into follicle structures is a pivotal factor in the control of sodium\/iodide symporter expression. Endocrinology 147: 2035\u20132042","journal-title":"Endocrinology"},{"key":"BFncpendmet0449_CR9","doi-asserted-by":"publisher","first-page":"5692","DOI":"10.1210\/jc.2005-0800","volume":"90","author":"R Bruno","year":"2005","unstructured":"Bruno R et al. (2005) Modulation of thyroid-specific gene expression in normal and nodular human thyroid tissues from adults: an in vivo effect of thyrotropin. J Clin Endocrinol Metab 90: 5692\u20135697","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0449_CR10","first-page":"3228","volume":"84","author":"V Lazar","year":"1999","unstructured":"Lazar V et al. (1999) Expression of the Na+\/I\u2212 symporter gene in human thyroid tumors: a comparison study with other thyroid-specific genes. J Clin Endocrinol Metab 84: 3228\u20133234","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0449_CR11","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1210\/jc.2003-030542","volume":"89","author":"L Lacroix","year":"2004","unstructured":"Lacroix L et al. (2004) Expression of the apical iodide transporter in human thyroid tissues: a comparison study with other iodide transporters. J Clin Endocrinol Metab 89: 1423\u20131428","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0449_CR12","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0303-7207(97)00108-1","volume":"131","author":"N Uyttersprot","year":"1997","unstructured":"Uyttersprot N et al. (1997) Moderate doses of iodide in vivo inhibit cell proliferation and the expression of thyroid peroxidase and Na+\/I\u2212 symporter mRNA in dog thyroid. Mol Cell Endocrinol 131: 195\u2013203","journal-title":"Mol Cell Endocrinol"},{"key":"BFncpendmet0449_CR13","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1530\/acta.0.0760651","volume":"76","author":"C Thomas-Morvan","year":"1974","unstructured":"Thomas-Morvan C et al. (1974) Thyroid proteins and hormones synthesis in human thyroid cancer. Acta Endocrinol 76: 651\u2013669","journal-title":"Acta Endocrinol"},{"key":"BFncpendmet0449_CR14","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1210\/jcem-43-2-466","volume":"43","author":"LJ Valenta","year":"1976","unstructured":"Valenta LJ (1976) Thyroid peroxidase, thyroglobulin, cAMP and DNA in human thyroid. J Clin Endocrinol Metab 43: 466\u2013469","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0449_CR15","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1210\/jcem-45-5-1089","volume":"45","author":"P Fragu","year":"1977","unstructured":"Fragu P and Nataf BM (1977) Thyroid peroxidase activity in benign and malignant thyroid disorders. J Clin Endocrinol Metab 45: 1089\u20131109","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0449_CR16","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1530\/acta.0.1010025","volume":"101","author":"C Thomas-Morvan","year":"1982","unstructured":"Thomas-Morvan C et al. (1982) Thyrotrophin stimulation of adenylate cyclase and iodine uptake in human differentiated thyroid cancer. Acta Endocrinol (Copenh) 101: 25\u201331","journal-title":"Acta Endocrinol (Copenh)"},{"key":"BFncpendmet0449_CR17","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1210\/jcem-71-5-1224","volume":"71","author":"M Schurch","year":"1990","unstructured":"Schurch M et al. (1990) Cold follicles in a multinodular goiter arise partly from a failing iodide pump and partly from deficient iodine organification. J Clin Endocrinol Metab 71: 1224\u20131229","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0449_CR18","first-page":"3484","volume":"60","author":"A Boland","year":"2000","unstructured":"Boland A et al. (2000) Adenovirus-mediated transfer of the thyroid sodium\/iodide symporter gene into tumors for a targeted radiotherapy. Cancer Res 60: 3484\u20133492","journal-title":"Cancer Res"},{"key":"BFncpendmet0449_CR19","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1089\/105072502753451922","volume":"12","author":"A Boland","year":"2002","unstructured":"Boland A et al. (2002) Transposition of the thyroid iodide uptake and organification system in nonthyroid tumor cells by adenoviral vector-mediated gene transfers. Thyroid 12: 19\u201326","journal-title":"Thyroid"},{"key":"BFncpendmet0449_CR20","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1365-2265.2006.02477.x","volume":"64","author":"L Lacroix","year":"2006","unstructured":"Lacroix L et al. (2006) HEX, PAX-8, and TTF-1 gene expression in human thyroid tissues: a comparative analysis with other genes involved in iodine metabolism. Clin Endocrinol 64: 398\u2013404","journal-title":"Clin Endocrinol"},{"key":"BFncpendmet0449_CR21","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1089\/105072501753271699","volume":"11","author":"L Lacroix","year":"2001","unstructured":"Lacroix L et al. (2001) Expression of nicotinamide adenine dinucleotide phosphate oxidase flavoprotein DUOX genes and proteins in human papillary and follicular thyroid carcinomas. Thyroid 11: 1017\u20131023","journal-title":"Thyroid"},{"key":"BFncpendmet0449_CR22","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1210\/jc.2004-0779","volume":"90","author":"L Hooft","year":"2005","unstructured":"Hooft L et al. (2005) [18F]Fluorodeoxyglucose uptake in recurrent thyroid cancer is related to hexokinase expression in the primary tumor. J Clin Endocrinol Metab 90: 328\u2013334","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0449_CR23","first-page":"4102","volume":"83","author":"B Caillou","year":"1998","unstructured":"Caillou B et al. (1998) Immunohistochemical detection of the Na+\/I\u2212 symporter in human thyroid tissues. J Clin Endocrinol Metab 83: 4102\u20134106","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0449_CR24","doi-asserted-by":"publisher","first-page":"4416","DOI":"10.1210\/endo.139.10.6329","volume":"139","author":"SM Jhiang","year":"1998","unstructured":"Jhiang SM et al. (1998) An immunohistochemical study of Na+\/I\u2212 symporter in human thyroid tissues and salivary gland tissues. Endocrinology 139: 4416\u20134419","journal-title":"Endocrinology"},{"key":"BFncpendmet0449_CR25","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1172\/JCI1259","volume":"101","author":"T Saito","year":"1998","unstructured":"Saito T et al. (1998) Increased expression of the sodium\/iodide symporter in papillary thyroid carcinomas. J Clin Invest 101: 1296\u20131300","journal-title":"J Clin Invest"},{"key":"BFncpendmet0449_CR26","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0002-9440(10)63272-5","volume":"165","author":"S Trouttet-Masson","year":"2004","unstructured":"Trouttet-Masson S et al. (2004) Evidence for transcriptional and posttranscriptional alterations of the sodium\/iodide symporter expression in hypofunctioning benign and malignant thyroid tumors. Am J Pathol 165: 25\u201334","journal-title":"Am J Pathol"},{"key":"BFncpendmet0449_CR27","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1089\/10507250150500649","volume":"11","author":"D Russo","year":"2001","unstructured":"Russo D et al. (2001) Absence of sodium\/iodide symporter gene mutations in differentiated human thyroid carcinomas. Thyroid 11: 37\u201339","journal-title":"Thyroid"},{"key":"BFncpendmet0449_CR28","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1677\/erc.1.01164","volume":"13","author":"J Di Cristofaro","year":"2006","unstructured":"Di Cristofaro J et al. (2006) Expression of tpo mRNA in thyroid tumors: quantitative PCR analysis and correlation with alterations of ret, Braf, ras and pax8 genes. Endocr Relat Cancer 13: 485\u2013495","journal-title":"Endocr Relat Cancer"},{"key":"BFncpendmet0449_CR29","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0303-7207(98)00027-6","volume":"140","author":"C Missero","year":"1998","unstructured":"Missero C et al. (1998) Molecular events involved in differentiation of thyroid follicular cells. Mol Cell Endocrinol 140: 37\u201343","journal-title":"Mol Cell Endocrinol"},{"key":"BFncpendmet0449_CR30","doi-asserted-by":"publisher","first-page":"4238","DOI":"10.1158\/0008-5472.CAN-05-0047","volume":"65","author":"JA Knauf","year":"2005","unstructured":"Knauf JA et al. (2005) Targeted expression of BRAFV600E in thyroid cells of transgenic mice results in papillary cancers that undergo dedifferentiation. Cancer Res 65: 4238\u20134245","journal-title":"Cancer Res"},{"key":"BFncpendmet0449_CR31","doi-asserted-by":"publisher","first-page":"3028","DOI":"10.1210\/jc.2004-1394","volume":"90","author":"V Porra","year":"2005","unstructured":"Porra V et al. (2005) Silencing of the tumor suppressor gene SLC5A8 is associated with BRAF mutations in classical papillary thyroid carcinoma. J Clin Endocrinol Metab 90: 3028\u20133035","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0449_CR32","doi-asserted-by":"publisher","first-page":"4264","DOI":"10.1210\/jc.2004-1426","volume":"89","author":"JA Fagin","year":"2004","unstructured":"Fagin JA (2004) Challenging dogma in thyroid cancer molecular genetics. Role of RET\/PTC and BRAF in tumor initiation. J Clin Endocrinol Metab 89: 4264\u20134266","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0449_CR33","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1210\/jcem.82.5.4062","volume":"82","author":"F Arturi","year":"1997","unstructured":"Arturi F et al. (1997) Early diagnosis by genetic analysis of differentiated thyroid cancer metastases in small lymph nodes. J Clin Endocrinol Metab 82: 1638\u20131641","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0449_CR34","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1089\/thy.2000.10.211","volume":"10","author":"HJ Park","year":"2000","unstructured":"Park HJ et al. (2000) Expression of human sodium iodide symporter mRNA in primary and metastatic papillary thyroid carcinoma. Thyroid 10: 211\u2013217","journal-title":"Thyroid"},{"key":"BFncpendmet0449_CR35","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1530\/eje.0.1430623","volume":"143","author":"F Arturi","year":"2000","unstructured":"Arturi F et al. (2000) Sodium-iodide symporter (NIS) gene expression in lymph-node metastases of papillary thyroid carcinomas. Eur J Endocrinol 143: 623\u2013627","journal-title":"Eur J Endocrinol"},{"key":"BFncpendmet0449_CR36","doi-asserted-by":"publisher","first-page":"5627","DOI":"10.1210\/jcem.86.11.8048","volume":"86","author":"MR Castro","year":"2001","unstructured":"Castro MR et al. (2001) Immunohistochemical analysis of sodium iodide symporter expression in metastatic differentiated thyroid cancer: correlation with radioiodine uptake. J Clin Endocrinol Metab 86: 5627\u20135632","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0449_CR37","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s002590100509","volume":"28","author":"JJ Min","year":"2001","unstructured":"Min JJ et al. (2001) Relationship between expression of the sodium\/iodide symporter and 131I uptake in recurrent lesions of differentiated thyroid carcinoma. Eur J Nucl Med 28: 639\u2013645","journal-title":"Eur J Nucl Med"},{"key":"BFncpendmet0449_CR38","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1055\/s-0038-1625711","volume":"44","author":"G Schmitz","year":"2005","unstructured":"Schmitz G et al. (2005) Expression of the sodium iodide symporter in differentiated thyroid cancer: clinical evidence. Nuklearmedizin 44: 86\u201393","journal-title":"Nuklearmedizin"},{"key":"BFncpendmet0449_CR39","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1210\/jcem-57-1-148","volume":"57","author":"M Schlumberger","year":"1983","unstructured":"Schlumberger M et al. (1983) Relationship between thyrotropin stimulation and radioiodine uptake in lung metastases of differentiated thyroid carcinoma. J Clin Endocrinol Metab 57: 148\u2013151","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0449_CR40","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1210\/jc.2005-2838","volume":"91","author":"C Durante","year":"2006","unstructured":"Durante C et al. (2006) Long term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. J Clin Endocrinol Metab 91: 2892\u2013289956","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0449_CR41","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0889-8529(18)30317-7","volume":"19","author":"HR Maxon","year":"1990","unstructured":"Maxon HR and Smith HS (1990) Radioiodine-131 in the diagnosis and treatment of metastatic well differentiated thyroid cancer. Endocrinol Metab Clin N Am 19: 685\u2013718","journal-title":"Endocrinol Metab Clin N Am"},{"key":"BFncpendmet0449_CR42","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1210\/jcem-51-3-513","volume":"51","author":"M Schlumberger","year":"1980","unstructured":"Schlumberger M et al. (1980) Circulating thyroglobulin and thyroid hormones in patients with metastases of differentiated thyroid carcinoma: relationship to serum thyrotropin levels. J Clin Endocrinol Metab 51: 513\u2013519","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0449_CR43","first-page":"735","volume":"82","author":"D Russo","year":"1997","unstructured":"Russo D et al. (1997) Detection of an activating mutation of the thyrotropin receptor in a case of an autonomously hyperfunctioning thyroid insular carcinoma. J Clin Endocrinol Metab 82: 735\u2013738","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0449_CR44","first-page":"188","volume":"78","author":"CA Meier","year":"1994","unstructured":"Meier CA et al. (1994) Diagnostic use of recombinant human thyrotropin in patients with thyroid carcinoma (phase I\/II study). J Clin Endocrinol Metab 78: 188\u2013196","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0449_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2006.16.109","volume":"16","author":"D Cooper","year":"2006","unstructured":"Cooper D et al. (2006) Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16: 1\u201333","journal-title":"Thyroid"},{"key":"BFncpendmet0449_CR46","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1530\/eje.1.02158","volume":"154","author":"F Pacini","year":"2006","unstructured":"Pacini F et al. (2006) European consensus for the management of patients with differentiated thyroid cancer of the follicular epithelium. Eur J Endocrinol 154: 787\u2013803","journal-title":"Eur J Endocrinol"},{"key":"BFncpendmet0449_CR47","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1210\/jc.2005-1986","volume":"91","author":"S Pena","year":"2006","unstructured":"Pena S et al. (2006) 123I thyroid uptake and thyroid size at 24, 48, and 72 hours after the administration of recombinant human thyroid-stimulating hormone to normal volunteers. J Clin Endocrinol Metab 91: 506\u2013510","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0449_CR48","first-page":"3877","volume":"84","author":"BR Haugen","year":"1999","unstructured":"Haugen BR et al. (1999) A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. J Clin Endocrinol Metab 84: 3877\u20133885","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0449_CR49","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1089\/thy.1997.7.273","volume":"7","author":"M Schlumberger","year":"1997","unstructured":"Schlumberger M et al. (1997) 131I therapy for elevated thyroglobulin levels. Thyroid 7: 273\u2013276","journal-title":"Thyroid"},{"key":"BFncpendmet0449_CR50","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1172\/JCI107303","volume":"52","author":"AJ Van Herle","year":"1973","unstructured":"Van Herle AJ et al. (1973) Radioimmunoassay for measurement of thyroglobulin in human serum. J Clin Invest 52: 1320\u20131327","journal-title":"J Clin Invest"},{"key":"BFncpendmet0449_CR51","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1210\/jc.2003-030122","volume":"88","author":"CM Preissner","year":"2003","unstructured":"Preissner CM et al. (2003) Phantoms in the assay tube: heterophile antibody interferences in serum thyroglobulin assays. J Clin Endocrinol Metab 88: 3069\u20133074","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0449_CR52","doi-asserted-by":"publisher","first-page":"5566","DOI":"10.1210\/jc.2005-0671","volume":"90","author":"CA Spencer","year":"2005","unstructured":"Spencer CA et al. (2005) Clinical impact of thyroglobulin (Tg) and Tg autoantibody method differences on the management of patients with differentiated thyroid carcinomas. J Clin Endocrinol Metab 90: 5566\u20135575","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0449_CR53","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1089\/thy.2000.10.171","volume":"10","author":"C Westbury","year":"2000","unstructured":"Westbury C et al. (2000) Recurrent differentiated thyroid cancer without elevation of serum thyroglobulin. Thyroid 10: 171\u2013176","journal-title":"Thyroid"},{"key":"BFncpendmet0449_CR54","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1365-2265.2004.02060.x","volume":"61","author":"CFA Eustatia-Rutten","year":"2004","unstructured":"Eustatia-Rutten CFA et al. (2004) Diagnostic value of serum thyroglobulin measurements in the follow-up of differentiated thyroid carcinoma, a structured meta-analysis. Clin Endocrinol (Oxf) 61: 61\u201374","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BFncpendmet0449_CR55","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1111\/j.1365-2265.2005.02228.x","volume":"62","author":"A Bachelot","year":"2005","unstructured":"Bachelot A et al. (2005) Neck recurrence from thyroid carcinoma: serum thyroglobulin and high-dose total body scan are not reliable criteria for cure after radioiodine treatment. Clin Endocrinol (Oxf) 62: 376\u2013379","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BFncpendmet0449_CR56","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1210\/jcem.83.5.4839","volume":"83","author":"C Spitzweg","year":"1998","unstructured":"Spitzweg C et al. (1998) Analysis of human iodide symporter gene expression in extrathyroidal tissues and cloning of its complementary deoxyribonucleic acids from salivary gland, mammary gland, and gastric mucosa. J Clin Endocrinol Metab 83: 1746\u20131751","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0449_CR57","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1530\/eje.0.1440297","volume":"144","author":"L Lacroix","year":"2001","unstructured":"Lacroix L et al. (2001) Na(+)\/I(\u2212) symporter and Pendred syndrome gene and protein expressions in human extra-thyroidal tissues. Eur J Endocrinol 144: 297\u2013302","journal-title":"Eur J Endocrinol"},{"key":"BFncpendmet0449_CR58","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/78630","volume":"6","author":"UH Tazebay","year":"2000","unstructured":"Tazebay UH et al. (2000) The mammary gland iodide transporter is expressed during lactation and in breast cancer. Nat Med 6: 871\u2013878","journal-title":"Nat Med"},{"key":"BFncpendmet0449_CR59","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1007\/BF03345302","volume":"27","author":"R Bruno","year":"2004","unstructured":"Bruno R et al. (2004) Sodium iodide symporter expression and radioiodine distribution in extrathyroidal tissues. J Endocrinol Invest 27: 1010\u20131014","journal-title":"J Endocrinol Invest"},{"key":"BFncpendmet0449_CR60","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1210\/jc.2003-031027","volume":"89","author":"BB Chin","year":"2004","unstructured":"Chin BB et al. (2004) Recombinant human thyrotropin stimulation of fluoro-D-glucose positron emission tomography uptake in well-differentiated thyroid carcinoma. J Clin Endocrinol Metab 89: 91\u201395","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0449_CR61","volume-title":"MIRD Primer for Absorbed Dose Calculations","author":"R Loevinger","year":"1988","unstructured":"Loevinger R et al. (1988) MIRD Primer for Absorbed Dose Calculations. New York: The Society of Nuclear Medicine"},{"key":"BFncpendmet0449_CR62","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1210\/jc.2005-1651","volume":"91","author":"F Pacini","year":"2006","unstructured":"Pacini F et al. (2006) Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study. J Clin Endocrinol Metab 91: 926\u2013932","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0449_CR63","first-page":"648","volume":"47","author":"H H\u00e4nscheid","year":"2006","unstructured":"H\u00e4nscheid H et al. (2006) Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawal. J Nucl Med 47: 648\u2013654","journal-title":"J Nucl Med"},{"key":"BFncpendmet0449_CR64","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1111\/j.1365-2265.2006.02626.x","volume":"65","author":"C Potzi","year":"2006","unstructured":"Potzi C et al. (2006) Comparison of iodine uptake in tumour and nontumour tissue under thyroid hormone deprivation and with recombinant human thyrotropin in thyroid cancer patients. Clin Endocrinol (Oxf) 65: 519\u2013523","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BFncpendmet0449_CR65","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1210\/jcem-50-4-734","volume":"50","author":"JM Goldman","year":"1980","unstructured":"Goldman JM et al. (1980) Influence of triiodothyronine withdrawal time on 131I uptake postthyroidectomy for thyroid cancer. J Clin Endocrinol Metab 50: 734\u2013739","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0449_CR66","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1210\/jc.2005-1534","volume":"91","author":"RJ Robbins","year":"2006","unstructured":"Robbins RJ et al. (2006) Real-time prognosis for metastatic thyroid carcinoma based on FDG-PET scanning. J Clin Endocrinol Metab 91: 498\u2013505","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0449_CR67","first-page":"1366","volume":"45","author":"G Sgouros","year":"2004","unstructured":"Sgouros G et al. (2004) Patient specific dosimetry for 131I thyroid cancer therapy using 124I PET and 3-dimensional-internal dosimetry (3D-ID) software. J Nucl Med 45: 1366\u20131372","journal-title":"J Nucl Med"},{"key":"BFncpendmet0449_CR68","first-page":"619","volume":"45","author":"M Lassman","year":"2004","unstructured":"Lassman M et al. (2004) The impact of I-131 diagnostic activities on the biokinetics of thyroid remnants. J Nucl Med 45: 619\u2013625","journal-title":"J Nucl Med"},{"key":"BFncpendmet0449_CR69","first-page":"828","volume":"43","author":"P Postgard","year":"2002","unstructured":"Postgard P et al. (2002) Stunning of iodine transport by (131)I irradiation in cultured thyroid epithelial cells. J Nucl Med 43: 828\u2013834","journal-title":"J Nucl Med"},{"key":"BFncpendmet0449_CR70","first-page":"1403","volume":"47","author":"JM Woolfenden","year":"2006","unstructured":"Woolfenden JM (2006) Thyroid stunning revisited. J Nucl Med 47: 1403\u20131405","journal-title":"J Nucl Med"},{"key":"BFncpendmet0449_CR71","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1089\/105072503321582060","volume":"13","author":"SJ Mandel","year":"2003","unstructured":"Mandel SJ and Mandel L (2003) Radioactive iodine and the salivary glands. Thyroid 13: 265\u2013271","journal-title":"Thyroid"},{"key":"BFncpendmet0449_CR72","doi-asserted-by":"publisher","first-page":"5817","DOI":"10.1210\/jc.2002-020210","volume":"87","author":"RT Kloos","year":"2002","unstructured":"Kloos RT et al. (2002) Nasolacrimal drainage system obstruction from radioactive iodine therapy for thyroid carcinoma. J Clin Endocrinol Metab 87: 5817\u20135820","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0449_CR73","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1038\/sj.bjc.6601319","volume":"89","author":"C Rubino","year":"2003","unstructured":"Rubino C et al. (2003) Second primary malignancies in thyroid cancer patients. Br J Cancer 89: 1638\u20131644","journal-title":"Br J Cancer"},{"key":"BFncpendmet0449_CR74","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1530\/eje.0.1480395","volume":"148","author":"T Gruning","year":"2003","unstructured":"Gruning T et al. (2003) Retinoic acid for redifferentiation of thyroid cancer\u2014does it hold its promise? Eur J Endocrinol 148: 395\u2013402","journal-title":"Eur J Endocrinol"},{"key":"BFncpendmet0449_CR75","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1210\/jc.2003-030770","volume":"89","author":"BR Haugen","year":"2004","unstructured":"Haugen BR et al. (2004) Retinoic acid and retinoid X receptors are differentially expressed in thyroid cancer and thyroid carcinoma cell lines and predict response to treatment with retinoids. J Clin Endocrinol Metab 89: 272\u2013280","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0449_CR76","first-page":"3430","volume":"86","author":"M Kitazono","year":"2001","unstructured":"Kitazono M et al. (2001) Low concentrations of the histone deacetylase inhibitor, depsipeptide (FR901228), increase expression of Na+\/I\u2212 symporter and iodide accumulation in poorly differentiated thyroid carcinoma cells. J Clin Endocrinol Metab 86: 3430\u20133435","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0449_CR77","doi-asserted-by":"publisher","first-page":"3967","DOI":"10.1210\/en.2005-0128","volume":"146","author":"C Puppin","year":"2005","unstructured":"Puppin C et al. (2005) Effects of histone acetylation on sodium iodide symporter promoter and expression of thyroid-specific transcription factors. Endocrinology 146: 3967\u20133974","journal-title":"Endocrinology"},{"key":"BFncpendmet0449_CR78","first-page":"2449","volume":"84","author":"GM Venkataraman","year":"1999","unstructured":"Venkataraman GM et al. (1999) Restoration of iodide uptake in dedifferentiated thyroid carcinoma: relationship to human Na+\/I\u2212 symporter gene methylation status. J Clin Endocrinol Metab 84: 2449\u20132457","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0449_CR79","doi-asserted-by":"publisher","first-page":"4493","DOI":"10.1210\/endo.138.10.5571","volume":"138","author":"H Shimura","year":"1997","unstructured":"Shimura H et al. (1997) Iodide uptake and experimental 131I therapy in transplanted undifferentiated thyroid cancer cells expressing the Na+\/I\u2212 symporter gene. Endocrinology 138: 4493\u20134496","journal-title":"Endocrinology"},{"key":"BFncpendmet0449_CR80","unstructured":"Mandell RB et al. (1999) Radioisotope concentrator gene therapy using the sodium\/iodide symporter gene. Cancer Res 59: 661\u2013668"},{"key":"BFncpendmet0449_CR81","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1089\/105072504323150732","volume":"14","author":"C Spitzweg","year":"2004","unstructured":"Spitzweg C and Morris JC (2004) Gene therapy for thyroid cancer: current status and future prospects. Thyroid 14: 424\u2013434","journal-title":"Thyroid"},{"key":"BFncpendmet0449_CR82","first-page":"912","volume":"84","author":"SS Koong","year":"1999","unstructured":"Koong SS et al. (1999) Lithium as a potent adjuvant to 131I therapy of metastatic, well differentiated thyroid carcinoma. J Clin Endocrinol Metab 84: 912\u2013916","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0449_CR83","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1053\/j.semnuclmed.2003.09.004","volume":"34","author":"E Dadachova","year":"2004","unstructured":"Dadachova E and Carrasco N (2004) The Na\/I symporter (NIS): imaging and therapeutic applications. Semin Nucl Med 34: 23\u201331","journal-title":"Semin Nucl Med"},{"key":"BFncpendmet0449_CR84","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.semradonc.2005.08.006","volume":"16","author":"MS O'Reilly","year":"2006","unstructured":"O'Reilly MS (2006) Radiation combined with antiangiogenic and antivascular agents. Semin Radiat Oncol 16: 45\u20135055","journal-title":"Semin Radiat Oncol"}],"container-title":["Nature Clinical Practice Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ncpendmet0449.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncpendmet0449","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/ncpendmet0449","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/ncpendmet0449.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,11]],"date-time":"2024-02-11T04:35:51Z","timestamp":1707626151000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncpendmet0449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":84,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["BFncpendmet0449"],"URL":"https:\/\/doi.org\/10.1038\/ncpendmet0449","relation":{},"ISSN":["1745-8366","1745-8374"],"issn-type":[{"value":"1745-8366","type":"print"},{"value":"1745-8374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}